0001731122-24-000419.txt : 20240313 0001731122-24-000419.hdr.sgml : 20240313 20240313093047 ACCESSION NUMBER: 0001731122-24-000419 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240311 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RENOVARO INC. CENTRAL INDEX KEY: 0001527728 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452259340 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38758 FILM NUMBER: 24744747 BUSINESS ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 45 39179840 MAIL ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 FORMER COMPANY: FORMER CONFORMED NAME: RENOVARO BIOSCIENCES INC. DATE OF NAME CHANGE: 20230807 FORMER COMPANY: FORMER CONFORMED NAME: Enochian Biosciences Inc. DATE OF NAME CHANGE: 20230804 FORMER COMPANY: FORMER CONFORMED NAME: Renovaro Biosciences Inc. DATE OF NAME CHANGE: 20230802 8-K 1 e5493_8-k.htm FORM 8-K
false 0001527728 0001527728 2024-03-11 2024-03-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 11, 2024

 

RENOVARO INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-38751   45-2559340
(State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
of incorporation)       Identification No.)

 

2080 Century Park East, Suite 906

Los Angeles, CA 90067

(Address of principal executive offices)

 

+1 (305) 918-1980

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol   Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per share   RENB   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

  

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The board of directors (the “Board”) of Renovaro Inc. (the “Company”) appointed Simon Tarsh, age 63, as Interim Chief Financial Officer of the Company, effective March 11, 2024. Mr. Tarsh most recently served at Deloitte Consulting LLP (“Deloitte”), where he was last a Senior Managing Director in the Finance and Enterprise Performance Practice, and served global clients since 2007. He led a growing global practice focused around operational transformation, including supporting carve out transactions, joint ventures and hybrid structures, both in the US and in international locations, such as India, China, Eastern Europe and Latin America. He supported high growth companies with their finance operations as they globalized, and was able to advise them on their expansion, while balancing growth with appropriate controls. Mr. Tarsh received a Bachelor of Science undergraduate degree in Business and Administration from the University of Salford, Manchester, UK and an MBA from City University Business School, London, UK. He is a Fellow of the Chartered Institute of Management Accountants (1984), which is considered as a CPA equivalent. Mr. Tarsh’s deep financial experience over the length of his career offers valuable insights to our Company, particularly given the enhanced accounting rules and regulations affecting public companies. Since leaving Deloitte, Mr. Tarsh has been providing consulting services through his consulting company, Tarsh PB Advisors LLC (“Tarsh PB Advisors”). Mr. Tarsh is presently a member of the board of directors and chair of the audit committee of Onconetix, Inc. (NASDAQ: BWV).

 

Effective March 11, 2024, the Company entered into a consulting agreement (the “Consulting Agreement”) with Tarsh PB Advisors with respect to Mr. Tarsh’s service as the Company’s Interim Chief Financial Officer. Pursuant to the Consulting Agreement, in exchange for Mr. Tarsh’s full-time service as the Company’s Interim Chief Financial Officer, the Company will pay Tarsh PB Advisors $25,000 per month. In addition, Tarsh PB Advisors may be entitled to an additional payment in the amount of up to 30% of the consideration paid under the Consulting Agreement upon the achievement of certain milestones prior to the termination of the Consulting Agreement. In addition, Mr. Tarsh will receive 10,000 stock options that will vest upon the termination date if the Company hires a new CFO prior to such date. The Consulting Agreement has a term of six months from the date of the Agreement and may be renewed for successive one month terms. The Consulting Agreement may be terminated by any party upon thirty days advance written notice.

 

The Consulting Agreement is attached hereto as Exhibit 10.1 and is incorporated herein by reference. The foregoing description of the Consulting Agreement is qualified in its entirety by reference to such exhibit.

 

Mr. Tarsh does not have any family relationships with any of the Company’s other officers or directors and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

Ms. Puche, the Company’s outgoing Chief Financial Officer, said: “After more than 5 years at the Company, I am ready for a new phase in my life. I am fully committed to helping to ensure a smooth transition, including providing ad hoc consulting services, as needed.”

 

Mr. Tarsh said: “I am impressed by the caliber of the Audit Committee, Board and management team and look forward to working closely with them and Ms. Puche during a transition period.”

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
     
10.1   Consulting Agreement, dated March 11, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  RENOVARO INC.
   
  By: /s/ Mark Dybul, M.D.
    Name: Mark Dybul
Title: Chief Executive Officer

 

Date: March 13, 2024

 

 

 EX-10.1 2 e5493_ex10-1.htm EXHIBIT 10.1

 

 

EXHIBIT 10.1 

 

CONSULTING AGREEMENT

 

This CONSULTING AGREEMENT (this “Agreement”) is made and entered into effective as of March 11, 2024 (the “Effective Date”), by and between Renovaro Inc., a Delaware corporation (the “Company”) and TARSH PB ADVISORS LLC, a Florida limited liability company (the “Consultant”).

 

WHEREAS, on the Effective Date, the parties desire to enter into this Agreement pursuant to which the Consultant will provide the Consulting Services (as defined herein).

 

NOW, THEREFORE, in consideration of the mutual promises, covenants and promises contained herein, and intending to be legally bound hereby, the Company and the Consultant do hereby agree and covenant as follows:

 

1.         Consulting Services. The Consultant shall provide the Company with the services described on Schedule A attached hereto (the “Consulting Services”).

 

2.         Payment; Reimbursements.

 

(a)       Consultant shall be compensated as set forth on Schedule B attached hereto.

 

(b)       All normal and customary business expenses incurred by the Consultant under this Agreement shall be paid by the Consultant, and with prior written approval of the Company or otherwise in accordance with the Company’s reimbursement policies in place at the time such expenses are incurred, such expenses may be reimbursed by the Company or paid by the Company upon the request of the Consultant.

 

3.         Independent Contractor Relationship. All services rendered hereunder by the Consultant shall as an independent contractor. Any persons employed by the Consultant shall be deemed conclusively as employees of the Consultant, and they shall at all times be under the Consultant’s direction and control, and they shall be bound to the same terms as Consultant under this Agreement and under that certain Non-Disclosure and Confidentiality Agreement, by and between the Company and Consultant and in effect in effect as of the Effective Date (the “Confidentiality Agreement”). The Consultant shall have the full power, authority, and discretion to select the means, manner, and method of performing the services hereunder without detail, control or direction from the Company or its officers or directors; provided that Consultant and its employees shall follow the Company’s code of conduct, and other written policies as applicable, in all respects during the term of this Agreement. Neither the Consultant nor any individuals employed by the Consultant shall be considered employees of the Company for any purposes and they shall not be entitled to participate in any employee benefit plans sponsored or maintained by the Company. The Company acknowledges that the Consultant will have other clients that it provides services to during the pendency of this Agreement, and such services are not limited by this Agreement, subject to the obligations under the Confidentiality Agreement.

 

4.         Term; Termination; Future Services.

 

(a)      The Consultant shall commence providing services on the Effective Date, and shall continue to do so for a term of six (6) months or until the date this Agreement is terminated in accordance with Section 4(b) below (the “Termination Date”). Unless notice of intention to terminate this Agreement is delivered in accordance with Section 4(b) below, this Agreement shall automatically be renewed and extended for consecutive one (1) month periods upon the terms and conditions set forth herein, unless different terms are agreed to between the parties in writing.

 

1

 

 

(b)       This Agreement is terminable at any time by either party upon thirty (30) days prior written notice to the other party, effective as of the date set forth in such notice; provided that Company may terminate Consultant immediately for cause, which shall mean Consultant’s (i) indictment for, conviction of or pleading of guilty or nolo contendere to, a felony or any crime involving moral turpitude; (ii) breach of any obligations of confidentiality provided herein or any unauthorized disclosure of any Company trade secrets or other confidential information; (iii) performance of any material act of theft, embezzlement, fraud, malfeasance, dishonesty or misappropriation of the Company’s property; or (iv) material breach of this Agreement or any other material agreement with the Company or a material violation of the Company’s code of conduct or other written policy; provided further that, Sections 3, 6, 7, 8, 9, 10, 11 and 12 shall survive termination of this Agreement for any reason. For purposes of this Agreement, email notification shall be deemed to be written notice.

 

(c)       For the avoidance of doubt, any services performed by the Consultant for the Company following the Termination Date shall not be deemed as Consulting Services governed by this Agreement.

 

5.         Consultant Responsible for Taxes. The Consultant agrees to accept exclusive liability for the payment of taxes due on any amounts paid under this Agreement.

 

6.        Non-Disparagement. The Consultant agrees that during the term of this Agreement and for a period of one year after the Termination Date, the Consultant will not make negative comments or otherwise disparage the Company or its affiliates, their products or business, or any of their officers, directors, managers, employees, consultants, equityholders or agents. The foregoing shall not be violated by truthful statements (i) in response to legal process, required governmental testimony or filings or administrative or arbitral proceedings (including depositions in connection with such proceedings) or (ii) made in the course of the Consultant discharging his duties for the Company. The Company agrees that during the term of this Agreement and for a period of one year after the Termination Date, the Company (meaning its current and future Board members) will not make any negative comments or otherwise disparage the Consultant.

 

7.         Non-Solicitation. The Consultant agrees that during the term of this Agreement and for a period of one year after the Termination Date, the Consultant will not encourage or solicit any employee or consultant of the Company to leave the Company for any reason.

 

8.         Compliance with Law. The Consultant represents and warrants that the Consultant shall perform the Consulting Services in compliance with all applicable federal, state, and local laws and regulations.

 

9.        Arbitration, Choice of Law. This Agreement shall be deemed to have been executed and delivered within the State of Florida, and the rights and obligations of the parties hereunder shall be construed and enforced in accordance with, and governed by, the laws of the State of Florida without regard to principles of conflict of laws. In the event of a dispute, the parties agree to arbitrate all claims related to this Agreement before a single arbitrator in Miami-Dade County, Florida under the Rules of the American Arbitration Association.

 

10.       Severability. If any provision of this Agreement or the application thereof is held invalid, the invalidity shall not affect other provisions or applications of the Agreement which can be given effect without the invalid provisions or applications and to this end, the provisions of this Agreement are declared to be severable.

 

11.       Advice of Counsel. In entering into this Agreement, the parties recognize that this Agreement is a legally binding contract and acknowledge and agree that each party has had the opportunity to consult with legal counsel of its choice.

 

2

 

 

 

12.       Entire Agreement. This Agreement, together with all schedules and Exhibits made a part hereof and thereof constitute and contain the entire agreement and final understanding between the parties covering the services to be provided by the Consultant. It is intended by the parties as a complete and exclusive statement of the terms of their agreement, and they supersede all prior negotiations and agreements, proposed or otherwise, whether written or oral, between the parties concerning Consulting Services. Any representation, promise or agreement not specifically included in this Agreement shall not be binding upon or enforceable against either party. No person has any authority to make any representation or promise on behalf of any of the parties not set forth herein and this Agreement has not been executed in reliance upon any representations or promises except those contained herein.

 

13.       Amendment; Waiver. This Agreement may be modified only with a written instrument duly executed by each of the parties. The waiver by the Company of a breach or threatened breach of this Agreement by the Consultant shall not be construed as a waiver of any subsequent breach by the Consultant.

 

14.       No Assignment. The Consultant shall not assign either in whole or in part any of the Consultant’s duties or responsibilities hereunder without the written consent of the Company, and any attempt of assignment transfer or delegation without such consent shall be void.

 

15.       Written Reports. The Consultant, upon request, shall provide written reports to Company’s Chief Executive Officer with respect to the services rendered hereunder.

 

16.       Headings. Headings are used only for ease of reference and are not controlling.

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.

 

COMPANY:   CONSULTANT:
     
RENOVARO INC.   TARSH PB ADVISORS LLC
     
By /s/ Mark Dybul   By /s/ Simon Tarsh
Name: Mark Dybul   Name: Simon Tarsh
Title: Chief Executive Officer   Title: President
     
Notice Address:    
9480 NE 2nd Avenue, #73   Notice Address:
Miami, FL 33138   130 Sunrise Avenue, Apt 504
Email: MDybul@renovarobio.com   Palm Beach, FL 33480
    Email: simon.tarsh@gmail.com
With a copy to:    
clayton.parker@klgates.com    

 

Signature Page to the Consulting Agreement

 

 

 

SCHEDULE A

 

Consulting Services

Pursuant to the terms of this Agreement, Consultant has agreed to undertake the Services as set forth below:

 

·Consultant shall provide that Simon Tarsh serves as the Interim Chief Financial Officer of the Company provide services substantially similar to those as would ordinarily be performed by a Chief Financial Officer of the Company, including signing all applicable SOX certifications;

 

·Consultant shall assist the Company in its search for a permanent Chief Financial Officer and assist in transitioning such permanent CFO; and

 

·such other consulting services to and for Company as requested from time to time by Company and agreed upon by Consultant.

 

 

 

SCHEDULE B

 

Compensation
 

As consideration for the Consulting Services, the Company shall pay the consultant $25,000 per month, which shall be paid monthly upon presentation of an invoice.The Company agrees the Consultant shall be eligible for a target bonus of 30% of the total consideration paid under this Agreement upon termination of this Agreement, upon approval by the Board based on the completion of the following objectives:

 

·all SEC filings are filed on time (with permitted extensions); and

 

·a new CFO has been hired prior to the Termination Date.

 

In addition, Simon Tarsh shall be issued 10,000 stock options under the Company’s 2023 Equity Incentive Plan on the date hereof. Such options shall vest upon the Termination Date if a new CFO has been hired prior to the Termination Date.

 

 

 

 

 EX-101.SCH 3 renb-20240311.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 renb-20240311_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 renb-20240311_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Mar. 11, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 11, 2024
Entity File Number 001-38751
Entity Registrant Name RENOVARO INC.
Entity Central Index Key 0001527728
Entity Tax Identification Number 45-2559340
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 2080 Century Park East
Entity Address, Address Line Two Suite 906
Entity Address, City or Town Los Angeles
Entity Address, State or Province CA
Entity Address, Postal Zip Code 90067
City Area Code (305)
Local Phone Number 918-1980
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol RENB
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://enochianbio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports e5493_8-k.htm renb-20240311.xsd renb-20240311_lab.xml renb-20240311_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "e5493_8-k.htm": { "nsprefix": "RENB", "nsuri": "http://enochianbio.com/20240311", "dts": { "inline": { "local": [ "e5493_8-k.htm" ] }, "schema": { "local": [ "renb-20240311.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "renb-20240311_lab.xml" ] }, "presentationLink": { "local": [ "renb-20240311_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://enochianbio.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-11", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "e5493_8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-11", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "e5493_8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://enochianbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001731122-24-000419-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001731122-24-000419-xbrl.zip M4$L#!!0 ( -=+;5B8!6BLDQ8 .YX - 934T.3-?."UK+FAT;>T] M:WO:.-;?^15ZV>U.^KQ ;"X)(6GV(82T3'.;D$R[\R6/L 6H-;8KV5SZZ_<< MR08;3&XE;=K9>68F8$E'YZ9SDRP._CT=.63,A.2>^^8WLV3\1IAK>39W!V]^ M:W9;GSTZXU9"-:Y*X,J&NQ^2"'NY_7P\?6>=>><'BJ*SZ))ZELKX"& M5GLQ(-EY9ULWIKH&F5UKNFL0=^72JY;-W;OPT#WF Z;K^IJ(,U#(/AY=G2ZZ M!]G]%UVW T%=V??$B 8@0H14*QKE8GDG :0HF94"!-]+ V]\+YQZL6+&<%:$ MDZ84FWM4SCENLR5VQW-" XPH5^*.@O77@MW9AM:X8RB+ TK]>><^E3W5,6I( M085GPG.8S.RM6E+=+2]T S'+QCAJ3 V0(E@%#0]3G:[:YT?S7LSUK"&G;H][ M)J43'-/"XO1NW#',%_#@(>..SP8%O_S1V,6$ )PBBR+R$?O\FW/#=@ M;E"\GOG ;4M_>Y,/V#385FMP&T9M:Y '_U=8?;@URJW;F^ZK\O';9O,2_B %I%A\X.!*_1;)O%TB[S8F[^&0JL?S04\8 M7=N[9:!:@#_\VQPQUX;_@A.'#F[[U)'LB9#:+LAAU@)0@CH=UV;3]VQV:X A MJY5W=\OUAX/=.0(N']^:MY%-T/#AT2- E&^[0RJ8O"W?*@NH84CU[!%@CA&3 MRPA4906A=;![GCTC,I@Y[$V^#VK7(*;A!^2:CZ#'.9N0*V]$W8)^4(#Y!>^C M=MM\' ^SN?0=.FL0UW,9MO%I S65"5!_]87;-G-Q+> WZ'4>C@".I?5\&ERA MM6C*BSYJ2-&H%&$!$1>(!-B,-U*"SQ-NO\GSZ1BL835_J-3@8#L%]LD39>I% MI11S U#$!SI=)U8X&M2&5IP1).7?.0[#,U -$T*LIY*>J&(9H).2N"-B')%Q!+ED7&*>S)%??QP M_IC;V-#G3!"%.,MT.JW.^S1OE@?/)]O.FBV:RP=&>O8*"N#V17!, W:XP#Z& MLVA;'@5*LV9,W+*$4G+V^%G$OA1+0Y=K?L*R6F;BB%$9"G88+;\&=(E!Q4TI M^ @K&[A>R>O@1\2K/D^<8&$NEB>!M0V"6V$HCE3*3@-/+%H?3?LR>ADP$S,> M@Q,:>.>_EQ_*D&6#CYB3YRVR,EMYBI>DE'UF[@VT8>YC+Y0[\V#B.J!AP MMT&,/+A_']J2UOPJ=%CQD@Z4(TN:5#VJ&'B^ML?[)'K2\X+ &S5(!9]-N!T, ML8/Q*I\:WO,$X*.''SG4^DS*8-.EYW![GT2-,23=;B[:T0L4)?\*+@:>Y@__ M]0]SQ]C7I$7_3Y"PG:(A2?E#O4E,&_!HG^!B*U*'#^"K!3:""4 8$!P(B-?L MHN4YGFB0R9 'X&D.>O"OP,A(^M1-SEOLTQ%WP"7=,W.25B-)+ ($:GNQT+XG M59L@IHK$ ']NSCO7[>-<][IYW>YJ9G7;K9NKSG6GW27-\V/2_MAZUSQ_VR:M MB[.S3K?;N3C7=&L6;)3%9<3J Y5#R$0##[H>MTC9J%7W?BC#8YG_E(*N1X(^ MN;@ZBPA18-'"8V"X9U14Y%LL'GM6B%$4IABWUCPJ7\3G7_\ZN73^8[[K6B<0 M'#PI@DK.D0B MAD*&U U(X $T"RL4Q*SD/$',VI;]FGA]$@Q99+.8%0H><$"E/;6&U 5WT[0" M[&/N5:I_+]YA[(J47S'?$P'9BK\S"I$*DT&.C0$$$:J9V:\;$:*]P_M,PZ6* M@-LZ/,ZV$9_<'7-P.K[Z?;C[*!NAJU!H#X*&#=!'T'=HT]D,L&9NE@U)(9,T M)COYPS,JK"$QS0+!.>ZT*S^G5NC8S5B)^WZ$CRG'P40*F$+#9I8G5'&Q06!R M)K#TF%_1,S/2,YU@7[$!EUB:#+"0D:UFU9ON)W[-)^++\(FN*&NNI!:!^H+U MO?BS>761ZYRW2FN5:,5'/881.G9:P-AJ3RG8+403EZR8HT>H)-)G%B;+-N' MO4 2L'2P@L7K'ZS% >TY#,8X#M!AX2Y"WLBK[SZU[?C[HW%+I"]K,9FG*_#0 MH;X$=8P_J:SU(!#QQ&,F FY1)Z815E"4V!X$]E)F%"^GWG+R$^%4J0%*$7%% MP0=#(&FG9-8PZXH?.ZR?>+K*W0T%>$9J\:U;4QT7],^/5+ ;@,5LZ0)WR[/7 M++'NZ;OW_4_]RJ3Z9$N.>Q!8@0F8+[PQ*G7:E#\ M^22K(-O8PZ=@$=X2*@8 MV"OBC57J5;9 8JW.&/E Q2C77[QB'*<4XX0[#)C88V*-/Y]6Y>G1:'I6L;[) MT"[F24IT#XN"9K%2WZV9+U6D/\%:-U(BO:;33E17M=2:NDN^+?/4^%K^XE_W MRM\DWS63)H2]9^0/J[5BN5:#B-QXH+3A?^(I=OP%R6M+F30">8L'^8H@GR!3 MD397"\T8A+/%Y <-T3K0NO?U%J.Z6K4K=$VB/?\69,_&+J M"U$H3SKH%R7%.V#_O J5MJ/DW"N]SM2I;15W'_Z=L]=55]A,N<*F;0LF9?3G M%'(N,]L-=IIEQ]XY%V5*O\D-9DR8=(%F_K!LU(T<[B&'8D8NJ?A,VE0&:]QA M@2S35[N'OG(V?;\;7WNT?W7D3/B&Z2LGZ8,8HAN":,B>L?.,59=GU)]V%G]; M\/%"7'L3-YN[U@=ZUIKX.^_Z@TUP=S%=DK>5_.&I)TG3'3 '-S$?J#!&%D$J M)+D0EY"5@7%?DP!>GUCA\5__&8^]C>C,TIQ)TJKYPU9S#44K!.UD$73I09KI M_,7]]?GL;NMJ\F'WU!:_?]X$.:D9D\34\H? ]9W=GT3_L>@4D805)U^ <+A/ M'<*FS H#/L9"%#@C)G]TF>E%L.NAE;W_-^_>;<,UWA2,KM?7/_^LCC_@2X M]NJNK*C+!AXC-QW2G8UZGE.0U)5%N:[FM62,6I$Q^B!X ,J ]8;0C1(FF6V1 MWGIO!W]\.K_YS^7C8K3DQF3/\QQ&776H-&FK,M%(&JPZ2G1OMUK=O\]>K:]P M[M5>96K1)E//B!!@2)(2XB>VXO$\%ZF6:]':P463V'W'3?T3JY(N6*4 MH&-V\OI E7HN!3J)%*CK.=P"U-W!&9@?L$%.MO9<=HQA]_AC78[K&]>>51R2 MJK/W+:KSS.JRP!PLG49]55?,*BV:Y82ZI$YHS)6E:I1TSQ>I+_5(7RX%PU6. MYZK5.29T1.*BWU\7!YT^YM6H%HZ1NF;^4 M;E58L;IE/4RWHK[/6IC]'C'[VCD2/EW'RTQ Q.UGG?B3@40OLF3FSY/C+<>*A[>O,+/?46LIV]/ZL:_Y9]_JGQT_=6%B> M)^F^R_E#=/7 ^F[@69\+Q*>"C*D3,O)/HX1OZQ$?7^L;WG7@ZE'J_'@=_C'2 MB9:O7KW9HGD?.I_*7\^J-W_M/%$TJ4F2C%BJ'#S"_?#)D.%!J=Q2 MK99+ HH#L3S.-B <1(,,:KWL7Y+);%9'QR,.ARMBU1&+2[K+E6H]&LA%;*% MI._NJT)5W)FK8]4^'JO&,UL(*0?&LUC.@)7UKLD<**8)BW$)L*4?74]^ILC\ MB38B?]B.9)I+RS3]KN43\O#U93^]DQO/^U9-V]*SKJG_A:;9L\37^L[FJ\=W M(),T/+4')]O?+?WZGAK\9.WJ]'/K[09NPV4:(;ZR5S0$$\,<2'K!Q+B>2H%# MR50O("3:D<(+=;A*B_5M :@ :BYGA@H^X3 UFBL7L(46P<9UW^7=FB\=MP*8M4VL "FFO<\[Q^^5##]>.T;N6= M?'R5?1_@?@FQL@33[Y,+7Y64&CA_+!5\V5T%6ZNOW:??K$^\>9\\K;"3\5+_ MCHJ?GD!^UHYPZFA$QF0Z6 /RHTL+5H@1C'XN]A@H.'#!5UQY) %SJ23?K$]/ MF+Q)X%DN$?BNKO.1NM<[[ 1L1&HEHTR.&21G02A4ZGS,!:B9)R3:D!8DOY2[ MN0MU2D?(?=)V(B5,=MTG3=_WN!NH8BBT1./(8APZ'>9*O/-B1II"H"'!WC*K M>VEC9RN^&^?C>-@HU;C[6&E@T-_SP!QCJ=.>"V +K2Z>\B@;^T?8K#Z;^Z_U M&[BN-Z;"(QW7*J6ZMN(0)^I,M6S Q'O#FH@<1BSVV &T8K_&^GW4@C$CZ9=A2^1,E#1\,O(DO@>,)@$/3S Q!@1H M ,KF>+@1#-!<&3K*&YV>7F)HJ["/VV/T"SF(V4$U8?X)H.I0 $M!"BX'_3RC M+E6>-U9%#-#5T0Y% P-_:),V4N<+<(;DD@D5-6'3I:! @\4*JE.$X,#Q>N I M+8,.$B"\O+*V^N^?@0'W+$5HL.E2L3$\YFN4$&?]&5X MR?,Y,O3Q56G\:%&!!^+"0'>G:IV!QGU"Z9&Q.M;+9 ZQ'?JXN) T'M$ '8;" 80T8>A: +>(X1<6W:(^ZJ MV$V9PK[P1HAD[L;EZNK+0)WYZ5('1 [D@9;"1,C9 KEYKR! N'1VU-0C\2@= M20R=3]6UAA#6%\BIY]I(]LU[Q7],5LD)P\-$\Y6I7]8%JCHN&)L@#!B:$K4\ M] Y54\=^%+5ZR]RK5U\K-H(28/8(@H$8$,>C%$CKLDG4Y8#4@;$)[LV/G-F, M^8G($F0#^J$8Z(VC#2X8.@B&B(9*4"DP$CG=!RI5(5 )F\/$@R'@!%+W0K$P M,>B1N!4Z5(#U& !OM&8S=X@*92=C60%IM)8+1-0P(M(S;:.@W0][#K=R2[L%1H+/+4**,%:AS4PC)@8M<\3 M WL\@@T!C0:;'KN]+0U-W4KK;'-2^HKQQ"=26U&*1DQ/.$7RUTY#9)R&L@' MB-/YO \%0Z-W*)%(Y>,O7$"6!7Q:R&GO<=[L'C?_@+#QPY\_>PGAV[UQ._9N MN;1W*R2=(%&AKJH(H<%*2I^BS5"++NV5YQV:<8>YBU:6:T4=]&,0O@_XY&": MU748:6)D54G"]:OF-8X]#K1*)'D1B@:PBB6Z*\*BY"^'2>,(=\*]TEK&._EFN%0S#4)L(ZCZ/$H FN#&K/>PJ,T< IX<61%V$JDYX MTL4(JB924HN<*!VA@<'E$OK8N6*\BI=4;"^5J.-__DX-&Z1' 6#F9DN@L"48(VE>I_ 91I6 M#J'+.W"(X,1T JC>3-5/T/7,8D9P_&S3F<2@1,4RD^@CE"# " O"5;"4N-RPJCWD/7!'IE$R=8PJ$Z^ 1EUA/8 HYI>,:AEB M+6#@H0AM)BW!_?O61 Y ?PF!MN2M)KCZ 9=9:@)UV!NUEFGLGE&F+VGOY#&X MS"U*SO9@3JQ1#NF8J?6B:WW SBCT&G(_7"IVJ"%(U MJE&9\VH>0))N\?W_]&!5#R3&#+"H"[E,J8:!7J-KW;L$9]F(8Z)F/U#N6V"N M!\ZX1O!*+C0RPH0Y,C#A'E15$\FY8N@GX(F>E96[*\*)RYC-K-+41SW,D3T MHM1E;C92"XB/,:Z3VNRJJ@ID2N4U3Y2VM.&\I$%4"BT* >5X;, "%SQS/ M^XS:,<%.(.F))SZK7 P7O3-3!BFG*@K8>Z['Q Z%$O3J_LHO*M9%\7>O9)B) M-:I>HM4U654VT\YP8\58-6],Q88@XEV-"3PW /$['P%]ZG'.^RY2CN^6T%LP MI=W4A1/1/13+C_4]%/KIA@_PQ6'?N5>Z[Z!BA$V,2/PG=1WT_10?Q6(A]]$)Z+:Y3H M'Z5@M>I>Y99-3:-HEH;!:),,S2YSV2H#72[ZJ:H !"DLF&!!.+WOABVKI:;3 M4[S3,Y(775G6/Z,"5O\V^K=!)<.M$'6R0%4]J=XR/:8!U5>7;6$MW\:S-QB< M1F7'COH)+8*_H47LZ#KB9WP5:+.!Y;TG6LK_.[SR8@^O_- ;V;N=M^?-ZYNK M=O=GOCI[,ZE>O"F3BS8!HDK6_+C, TX*%[).&-HA5D:H.J2@3@WK:]JC ID$ MA*'!TX72'AM2IQ^EYCFUNQ%UP IMB)M>"AP-@Z$GGVK MO7K=K!%5F=OSR\2B*O,O^^(T_AI%(TY0*O$/4'RW8Y*/_?6PRF9_/"RI&]_Y MQ\'FH>TV_F:E^CG48.0<_A=02P,$% @ UTMM6#!S%C?1%0 +WL ! M !E-30Y,U]E>#$P+3$N:'1M[5WK4QM'$O^N*OT/<^22PE4"2^#8CB%4!(B8 M*@PN),>7CZ/=D33GU8ZRLPN6__KKQ\R^) C$8.ML7>J,M(]Y=/=T__HQH_W7 M@S=G!\W&_NM>]QC^"OS?_N!T<-8[V'_*?^'N4W=[__#B^$_1'_QYUOMU8V3B M])7HM&>I&.BILN)<78M+,Y5QBR^T1%\E>K0!+\*K;_U[4YF,=?Q*M#>@B[=\ M\U];6^)$JRA\)2ZS2&V]E6,EMK8.]H]/_ZB^MY6:&?>Z)]R5H4E3,WTE=O': MM0[3"3[0_G&C\CH.=\OJ3PINXH-#DX0JX>8.(QE\$#LP$VLB'>8W?%I90[5V=^5:GYV0*<]D:J/Z9:,]!B^!BI.50)S M.[DX'_A6Z8%0!2:1J3;P5&QB!<\0SJZ M..^_.QNN>#E1K@EZ#9?S.;ZM'<7=1QJ+#!W>&0J0R5D' JB@ J% MCE,CU&BD@E1?P2TKS$B\D4DP$9U.2^RT=YX):%V5&N_E3Q_+5)5[:#4;PSDU M/U3IM5*Q6*1PFLC8CDP">BZ;S5022 M4OE2QN9*)$:=QX(B\W1)2'*M(7LM$ M"6#+S'&F/IXC,YW)>%X>2+.!@[AKYX/N9?^U>'LHNL=_G/8O+OOB[.S(C0(' M<1*91(=21'JJ4Z!9I.501SJ=PZBHZ\41Q3:+4EFE__87%ALOME^T4Q#3]Z][ ME[UN'R6S)8!=2)M<9IH-%)H679S))-70?ZBL!A:C(*)4LDR21.=R+&998C,@ M*#YU/=$@GMA"06BPQ%$D9HFYTB#AI7LZ'N-TKG0 /6U*[&VD8Q4V&Q-8 #K^ M;MAR?O$>&D+>G%Q<]I@[.@81CBV0C)=6LP&K'XDWS=),$CVGVF+7@;E2,=#9 MTO+VU_'M5"(Y!5.S1;>!@2H.D?+ K:$2D1K+*)H#SLEB?G(X;SDF\0+"MZH, M;39"XQX5$L6 GO'#0$4U,E%DKNVK;YM_+W9F=; 3&%!(K\0/;8"=;<"UG6T> MTWW_]=8L5UC L6;#+Y9MU%UB4%UE=B(7EAES\%JGO":M7VRPK(-$#T$V0 E M)_U@HD* JJ)++H7/>:C4NE MIT-0L:1LBF#$R&Y YS#6!&Q09L%>62O41V0*3$3'098@%@9+4P,5 M8*X C]2@2,[7F=1+7F(32.IPEFB3-!O7B4[!( HY0\4)(W)&UJM.DP@#WY-K M,*EHDF4 :#>4<: *K>J>_2FQJ/VL2,H+5LQ,I --$D(W^Q$S]AL@_P7ACC!5Q*G45BD%T6=I5HB MOA.ZZ(<0'G>S+;K :?":++PEU'06F3GBZ)O: CD*<.\48; MSURK!,B9I1-PB=,Y4S:$68.I0JH#0:V*<'3D12APMUNPD.*87H-GIPI>!40X M:C9 DM 5)S>AC!L+*47M9[(4Q @H'+4\/U$)%8P>@2]25U$Z1=J,H+G$%D^; MQ.YY[!HR\\KVFNB*51HJ6%/GU@9ZA M+.(TX6W?/CP:@_^=HI4")6+!;%B# X!>IK"*G#-9M2XDFJCPW/((/L3F&OH: MPVB(B\M" 22XS(H@THAJ^5GLFT7 %B('@R[H+UCU!?-%%A"# =FASU+?T>MQE'4+LZ9;P.$!N044RBL-UU6^6NH!0<'Q0-0J_F58 M 7%&\< 0S(D1I(*$5XI6?Q2;SY^(*3PW(>V>P0L ]['9$'5.S5[#E]2QG0+> M"_@:?3!G3)Z!LT$ :JA0Y]L]<3$C2K_"OKT$4'J7 MG4K&V[]%27N@)R?%%VDS3)3\L#54(*K0VHRH? =Z ME>F1<[@J,)4>RT-[I#S\ZHGQ0X=L,,M9\DU*:AOP,KF!@/THG@$ RP%A5"%Y M\$'CY\W=]A.P G/+P9<48@-A_>GJ0&LQJCL"2L+>$0P\2 MI*R.KTQTA>U,32+!ZP;0K],L5'LX#A@(+B@8,O1"GE8)Q[(75 &P.9'81OBN MLMCYCY\4^X[L,?M&/3'3!'/58*7 M;1YC*S9*/<" T87TN$Y&"$,T;F59#]= MD_ R#F& @,?F1H!*E?3H?KT*7(8?93(+$1G-1HI:?'U%HYN N;1,CFGVE(( M#R2KFBVKNX7XC +9VL.W-O75DV($!0%K)MP1AR6S&'!^OQX)I!?R!YN-*VTX M""1N&%3-5\TI6O54YR79'F6))CAP/=F**';SOTC55]4J"E-?&V.,$5X/U3]WA) ME2"GI29758\ '5&K]1@59RJKZN+[P".W*O+@_HK\!&/>*('RRNC0K\/09$/R MG^>%+^"6ZM(H!?*X+.XAV)5X,1CJ72YKY)I0I@; !KQ\L\]37#?WZH M7#*%U"X517@T6G!DZ$!^Y"SN0K21%!T%8L#]43!O]=&%C$OE-EXF9IRWI*6. M+8HP0S>&A$M.38;!'LI24' %A7'-Y#*3G]^;R05[79@;L!, 71]$WFXV;N G MPJ-2:&UY9)-, 7OY['X2J@&W=*XD7!RE+D)67_6MNM+ R!\YX$"R#TK$"M') ME7(!B1*,H%1;Z*>Q+'PL1R,0.NC$4B\Z0;N(AI,:\5G$5FZW1^XI'W9N^62$ M23@$#OW@ISS22BC.#1RO_Y6!B$],%+J8-3P/-WBAH/\R-A1'*>LYMOE.D24 MJD89F- 4+O%L&3HV&PDO0X*_5(N#(AWB M,8\I!/IKFR9,5KR2#'6:^!952$]N:LSW$!X-%5AE#AHT&UQN%#MOEA -H>K2 MNT\8,NDG7*JH.500&$Q&+F:+"#Y.:'6,!8I4F%%(H68\O+9Q(>TO*INN0!#A M/7:$HD6I5Y]Q&'$0\M#(!+,C $D3( *%L',YQA;N*.4TGHIQE: $0+.6AUO-O;BXGWNS5H1 JL$G^PK050':W[TLO7P M= 3FFE7:)FH+:5K[B\EDDB\R36THR>0],W%K^2]O6]L_:5 M*#Q%5E*,%%:"1BTV(AR5CTP ZCV2USP0,$29JS98R\,OGP&DNFPYD9* %8XF MQB4-2@*QO.RH<%@IQSG$>+KZB-%\%^DOL@G(9&="^\A1;-]5L^=%$;R?QG)F MLQ;1*8?IB[1\)8$,N,,G&# 6$RS-87!G);^+]1@)E>NF/CY>'IC]!XE#VXB) M9="J@9Y%*@\W@>"2)L.6ML4I3U5=.>= DEG,ZO7F7$Z,KH9C@:)4?!!)/<5J M&<94K@:]')+D0#(T"^!OC$%)]SY"QEB\T7*JMXX1MARA#P*3]#L'BB0O[M7* MY]R=@E@&,A8E61!=:TV@O:'YSA=8IWV/%5:LK3Z(0.*\1F>M3SD42,$MNSRL MY$"CTX>RG^$HGT%4PI9GMP7]$P+6"ZY.,=%F'UOC)Z+AFT>.RRZ MYV@PB@,LK3&LX+S2QZ^$4J>W-,T+V^V@4+$;;/GY^LRY)C!4L *2/!1FF8;1 M.@IVT+E/A7U)PX=H>(G3J!"LBEBQ@YJB=!GY XM[7:K*"EQ(,X[U)^4M?SUW M+(OM%9HW7?B2/1*$4K4,.QQ.^V%C%(KF',I$@H1+-@AF-C-)FL4HV*GQF)$1 M [N/ 4^'9JQXKR6\W"$=1LLV#+V/D[T$+46[X4E_2>0F#X3N-5IEOJ= M9U2N ^L2I>5N^">]B2A:I7-KIY[FTA(0+HEM0][ZTK MGG"MPF#0%)"#I]R0BQ!Z'A/TR).+<_*@I2S(5Y1W9ECJK4(&QYQ-C]78I+H$ M,_(705HPZVDL5H27(U.8Y5:5/"/>)2=S.7% 6R04*EOBPW()>NX:L_/D=R-R MT-1S!+!8LX&UM93R0_/(04GV3Y;63[FHJC>C5%8 ;3J_ALL0QB #-JW4'VP+ MT'Q<%D]FE+(0OD(:^-ILY$&\ZL@I<>_'CJ@/1C'*<^M5[PO'5B^ZX7P++@U+NQ \UHA MVW+W7J*3[I-A%2:Z73A3$X+PTO[)R&VPE/DJTN1ZT^.@V^8%K[$Z)B\QR 6( M0^#7U&>MO)H JLPK$] )@H_0!S9V4[G"367E;@V5(@.HEER_3K1M-K2$"U+? M/K=6KB1=BUCG/D7/Y6 U6$AKH>^RB;R!4Y(>]-H,"S$G)B)%BAO)T#"65-%B M<9)/M\#SB<_THL]="1<5@1QLQ(LO%: N1*'9_) "A:>F,X[BY+,1?'X#2E*" M42[%H:KP7XO2>^86I?'0*E^X*;[&I=%O_6K5- MXI[C"3> 0*=>FG0TT6H$P,Q7)%]P#I55GMLAXTKWP*;?O*UMS>7.?5+[!9=? M<_6@=;$R_Y6VMF366R#,!BG)>=A$49EWP$C3;X%Q&[2B;ZF6.U*CM-9C?J;& MZ;EX?SHX[_7[@DX]N3CAPPJWCBA&@D'W<.S MGCCJG9WUWW:/3L]__W6CO4'?WW:/C_WW>X^J=&1:'NX ,8[DS(+K[S]MD,N^ M/[CT'0!^H)T-?A:IF6UXMWYP+(XN<)3GOV[L/-S)8.YTJC?0[I^O*L<_#8Z+ MKG.RE2\^YGCH$*CN^6!A2/#/Y4J0K:I>OAJU%H>Q,A0"1E[VSB_^Z%Y>B-/S MH^U5D:X;CL):R]FCRYE[RFG'%S\^Y /YTMIE =?;SU^,M?8S_",RZ?V*1X/ M]T$6<^'_:*I]K((3 YG8R6J)/H?=RYSXRHN !U2AUPIJ MC %N4G]UD\/QU8GHAO<6?![:XK*2-/R6M.XCK07>;-8-0V D'E"W)M5-0_OE MV*G.S)6AVWM.Z 1FAEG"M96X96A!).%THAM*\5O_O'/;JJH,6:H#N[Q;9=GN-U-9]EW4@C%C'TUN\@5X2#7/ M1Z][Q^_.>GR\\F/_VD3U5Q$>LY\E94#[AZA@W;\// "_YMO;/^L84%CIW/E: MX52U[*R\[9FJ@/(SCR@UF6()$.USR(^-*Y^B1,Y_WI M\>#UKQOT2S8/;CB D7^+(!8C@YV7K"K0IMYT\T;;TY]/AR8"8OS0>;E;M<_P M_UN.-)=I.8I%!7K,+>3>*=5M3UT Z43',@[PG Z?L:YMJO.MYCEK+'W!7C4? MT05@54'"2BOHYMID$9Z'&$+CB8ZH$JAR4(*\8^\M46S#Q0H*_$O'A!7[ MO?H7_Z'S2_-C,>Q> 6$>#+[0?[O/9W6SNL4\7(OK_<45:V)L6I$U'5,MOE7T MXRWYWE*8/2:8;Q(9RMYS8U@6B?4UM%N;A(;V9OLFFHVCDXL]?&$M(BLH(L0L M=]YI83'+Y<5^RW%^CJKU)3MXU@^=HJNG#+HUG[)5/I#8V3.J]*%;I4J]KRP. MC]C374#YLS4H7VU0_N6DZ4[X_/!;P^?NURW :C D?]2>70W8QD'75G^[J'3H MQX+#T/+EQ:S/'.23X2&Y<_[WS)XB&4'YN(!VC"]_)PD*5*8/7@'0Q-GY&[LMG_,]VZ8E+;@ ME>=>G'94KRSCPQ%O.TZMY;<$^)^G<+7=?"3)4'+]GR,5;2\IG3)7',MEZ(AK M#6#Y$7^1:0T%[@ %4*+ZO:/\X!ZLSH3/CHUHVS?YYTE0*E*T_G0V,&T.?K)& M>"O+5A'#5 "$TR8?VN SH:.;>&^6"U#43XSY_X9G&P>GH)A"/G:Z577,O>;4 MUN)&DTZ;5+=-#4 H,ZN=KI\K_[SH?*>]LRMZ=.H6_NHD[NF[4N)M!/K;:3LZ M Y9W VZ+/N%KURSW?84_=).?D[UP)*'&735UEC4;=^/98P2"/J^Q?_SKR;N/ M^>/)7_C'D1^8IK7&GN(/7E-,DWXH^W]02P,$% @ UTMM6,//7 \K P M[ L !$ !R96YB+3(P,C0P,S$Q+GAS9+56VW+:,!!][TS_0?6[,8:F#022 M*:3),"&7@29->>D(>4TT,9(KR5SZ]95\XV(@0%N>Y-USSNYZ=V4:%[-Q@"8@ M).6L:;FELH6 $>Y1-FI:CWW[2[_=Z5CHXOS].Z1_C0^VC:XH!%X=77)B=YC/ MS] ='D,=70,#@1479^@)!Y&Q\"L:@$!M/@X#4* =2:0Z.BE5W"&R[3UTGX!Y M7#SV.KGNBU*AK#O.=#HM,3[!4RY>98GP\7Z"?855)'.U\JR<_O:CWU))=:CSZ-[=AI=8S8@?7S3 OR@?HYD1U!CI:^_&T M5>M4?O3);1*R(,JDPHRLX#V5$Y;!)T[B7('2 MC=!/"91F4 _6HUK>2XI)N!31N/HZ2JYR#:+$YEB]3%F-IQU M<%$IDN#=L_/X' J0FAY7U=6&E)]"=G,)#D@4'$5=Y+>+F=JS=UEXR=E&]8"'AU:N*1#\QY*[1K]8 M:\-972[]O+Z #5TN%PJQPC+ONDZ3#T&7DUAJ!\4\V1G/-B;;K=A5MS23WB+3 M0Y)8O('#DLAX1R2QY5+?%%]N@YN#&:'JOD&W?!QV!MW(<2!0,K,$HZ1,*(56_>QZFY/YRUF_"R/&@+"(Z;$_)!!6*9D#\=U8_$G M8+]&9/BD">9_P;%ACYB"8O!-(]!P$C5]_ -02P,$% @ UTMM6'%+E6W] M"@ @(8 !4 !R96YB+3(P,C0P,S$Q7VQA8BYX;6S-G5UOX[@5AN\+]#]P MW9L6&,<3!RV0[&07&4^R,#:;9&//;-M%L: EQA%"DP$E)_:_+RF)LD3Q2$J* MDIR+&8_X'NJE^)BDOHX__;C;4/1"1)IP=CXZ/OHX0H1%/$[8^GST=3&^6,SF M\Q%*,\QB3#DCYR/&1S_^\.<_(?GGTW?C,;I*"(W/T!<>C>?L@7^/;O"&G*&? M"","9UQ\C[YANE5;^%5"B4 SOGFF)".RH-CQ&?K[T?1XA<;C ?5^(RSFXNO] MO*KW,T[/)Y/7U]8CQ%_S*Q5-Z%/'-L H7&+'T;)GHZR4NUM*7$7H""FEY -LUVFCKC)HXMKL M'1$)CR_9^UR;T9[LR^^.R/Z'!M3CG3=AR3-,WV6^'NG<]@UYWQ$_Q+D_TG*< M)^\[TK7(_XOMK&WYS8?7?ERIVG@M/S4LDETF)S 2:Y.JBHX1.-]#/C&4=5>U M\ZA1+U6C.1?MMJN9,:\S)='1FK],8I+(NJP8Q@"]ZZ&_T[8Y%UC% M04 SQ"$X6]2#4!7EB:,+QK:8WI-G+KKP:)SPMVUW\5.)@$3(=#J0H#T,JSA-)M=L0/0RU ME*[I :R:W!BRH(BQ>P-9*>0HU_N'Y)+%@Q"I='X ,6S:\2A% <+1=-:'AE3[ M!.,J22-,"R]70-4#S-0)I[N9KM9$6%I7%OBB@W(G&;"+ ^"!<"4R4 A0TJ'"J&7 MGM=W"5BF'F($FV/*W!)@-]FDH*D)B 2K,8"&@S9_IM0+$3,Y,@E,YRPFNY_) M'FQ72^>6"FQW60&$ >$3K=# M@" 9A)I1/D&:LXB+9UY[W&'&MW( W,]X#*]0>J+<0C6H"4VT.D," FR(3P"S M1NB'XID4Q-5[/'D%2-7@A;B+.)8'*BW_N4X8.0;;;]6ZI:O#;I,IBS @DF!W M #^E\H/^@%0,NF6A0#-]0U.G_J&9#H5F&C0TT_= LWSE@4!S\H:FGOB'YF0H M-"=!0W/R+FADQWL=:V;RXZU8\E?;P]F@T@LR;:M68 ZR\'!I>>N#106H]8P* M\8E)OK"Z%7>"OR0L@I?,D-P+,(!I*S6&-CQT[ ;[^*D6Q#K.ZUA3+,I[OR1: MYF>4:9JT#S&%)CQ(FL9Z!Y="[1.).YYFF/X[>>X\$;>+O>!A-6R%I*$,#Q6; MO3Y@BA@D@WR<6)>XJAL:UE?)C')WKP!;;!U> :X5!@&!S5'[%>#BZDDABY#N<[3U7B582*U#]^U,F;+2OO\MB>&P1TKGJYTZ;N<:LHB-[O($V2R%ZHBT"=;"Q)MY?RX/YZNEDE&;2>7;8FS.0DP5\U( M1GD0; "F3!;R,L0?T/'TKZN_(1WEN/MO^%)@E3QVL=^L. 6R3UE5KB#HL*@Y ML$B"0 'V9=)PPU$I18761W:JAEE+FN;Q0&T>DV1ZTO?Z.O/0WY ME[OH49HBP L)=IGKH=]FTAS^ZYH@$.@PUCHI*:5(:WV\D'"8LM;]BX"UMT7 MNF<1L YQ$; >N@A8>UL$Z-T6*4+DN'2[HLD: \D).]6NH>BP;/)AD0:%"NP/ M'#.J$'2(<9W1,D]QIM+SBTV^_ROYP=)*0.8J89A%":95>D3;%?'^$&>T##1?@=.C#X.A829;.!5A M.I=A%7A(=>GZ4GKQ ,9OA-*?&7]E"X)3SDA<7$NQW2GJUKM]8J;'=O.A&4 < M!$Y#' */SJB@\9.*0CJLO!+FA:1OG&Y9AD7^+KFPC4R SBTY@,TF,88H(%+L MS@!"*C$JU'Y>T"ZR1U2+K.)WA\ &0G+'KVMWFC;>VK9J V*FTR#T#G>9\^.P M-BZB/+UBF1'U>Q')"_F",UQZ ]L+R5V_5-EEVGR;TJ8-"*%.@^#[DU6,2A6# M-5/>4L:(F5QJK7G'4^*&RGWBF);%=NZ82A(0'C9?'1ED!-):+RPL-IC2S]LT M822%)R)#Y98%J\4F"PU)0"S8? $LY%*DM5Y8N-P0L9;3VT^"OV:/97Y6L&V MVBT;G9:;C%BE ;'2Y0]@1H>@(D:GU/4#S^Z04+S(L@BWU")UC UHUF"FI0L) M&,AUCRYS@.1BO29S:B>W!Y>XC5$CE?&%H/&PKBF"((1 MT!:T+*[_5H"?W'G;%4VB*\HQ?)6EH7&<,:]MSTB6=Q $1$#;%90B+Q>B7.FE M_S]C]B2VSUFTOQ,\(D0]9956HU7?];>!T6Z9>5.3FC0-"@V(L[?X!0@\5(%J M=7RHS5@^+^:IA\95-C<>/2T>L3R M]LL53.H- 9?!>\,>@'5 2C6K2G\[/TD 60Q)_W]^2!"/7>P9+LLL]R1T\=9Q@# M8EV?O0UNCGDRUQL8!(1O=0N=ZJ6H7@%:J6?$RBK0[ZH2E-=B^_WR^J9K^4EN MUIOD7RN<$KGEOU!+ P04 " #72VU8FSM'3ED' #;5P %0 ')E;F(M M,C R-# S,3%?<')E+GAM;,V<77/:.!2&[W=F_X.7O28$Z'XD3;:3T-!AFC;9 MD+:[>],1M@!-9(F1Y #_?B4;4SXL^>3&)[E(B#F2SOL<6?:Q)%^\6Z4\>J9* M,RDN6]V3TU9$12P3)F:7K2_C]M5X,!JU(FV(2 B7@EZVA&R]^^OGGR+[<_%+ MNQT-&>7)>?1>QNV1F,JWT6>2TO/H Q54$2/5V^@KX9D[(H>,4Q4-9+K@U%#[ M1='P>?3;2:\[B=IM0+U?J4BD^O(PVM8[-V:ASSN=Y7)Y(N0S64KUI$]BF<(J M'!MB,KVM[71UNODIBE]P)I[.W:\)T32RO(0^7VEVV7+M;II=]D^DFG5ZIZ?= MSC^?;L?QG*:DS83C%M-66W9VULF_+4V/+%<3QF].^]V\^E_W MC,QZ8?NF9JYKM:+.7M,+1345)E=[:P_L%:$K8WL43AS%+O]=T'AZ*? M8[#_?,\;NIIHHTALRIHXF5">U__=VAR8=!KPJB3Q:&NL=FK?XM"GW;A=J3B2 M*J'*LB[K(BK>B]9Q]]Q8=!;$=A_3MK'DVT!/E4Q]=#8DI,?175"VB69H7MGV M$^?#D)-9-ZD*H&_+XED/<;3-Y5VI P M_YT19:CB:PCI(V,@[-\P87L4(O%^5$1HYOA @!]; XG_CGKCX=&(A'P\IYR[ M1(X(4"^OL@=B_P,3NU_G*P!_\^RN[_;2 F>_4P2(_\_7@O](+5($[JEB,K&7 M= 5@?V0,I'Z&2=VC$)7WC4B@M+>FX/P''_:!/"340Z9CP@N/AO:8#N.N,('"ZS_K8"LH8)>GTB4)A6SYI$,9-:(3X'EI"&:/DFB%Q*)P' M5H\B?"02NOI(UR'01Z90TB@Y9E >"NI[Q5*BUF,6UP\:Q[90V"B995@@"NU' MLAHE5A6;LF)*L!ZZMPB4/4I:"9*+$H*1B*5:R)W'Q0.9V?-Q/9!)<$BO*0@- M!TJ^^0+I*$&Y2A*+2V_^W#)!NZ%05)J#YXCP A"0^4JP]UZ&O0?'CI*'ULI\ M)=C[+\/>AV-'R45K96)B']B/=^I1+CTST%YC*'*47+1&(B;P_$ISI^Z5?&;% MRJ@ZZD6OB6$AV80/FBY*J5>VP%Y8J22?I$-3WPNK7$VGOJ[WP-7L&&,JP>RF@8XS?%C/5@ M(-,T$YMG-)Y9,8\I%"]*^A>4US#JL>0L9H:)V2=[AZ@8X=6UM=[Z.RVTV4'?3J6_D#=E#B:/D>O5"<BG_BE+0**"D M?5#138\S-,[LL+?N]B:/;L>,9Y0YLH*R1DGY?*(:9OM9/BKB=NR-U^E$WY4XSTP@8)%R>PJY2"-"3>K>$[$C/I7+U1;0@&C9'HA M<6AC[PPT]LY>./:B9'P^44ALB[7A]HRZFW V(_Z=9,$"X'TVF,0#4IO>OY=O M^7%[N56:^S&T'ZJQ>TRAP'&V2(;D-8TZ2YBA2>'2D DB8IM2;?>U>;+S^E+0 M .#LH02*1GF\_XUR_E'(I1A3HJ6@27&K'WK"[RT"C0+B'&*-7)00?)4\LY14 MOA!4>+SMK+8E'S]MI3O+0C1-Q7 @H><1(Q+!9I?9JASF?V M3-\30S8>AOC[2D#Y(TXHAL6BK9]7 WOAF%^^9P;EBYB%5LA"P7M-Q)/*%B9>WRL94^JF3_3V; ,D1, *H"%! MS$]?A +G<8%,4[>92,9/X[D5K>\RD[_#U/H7?&@0+ <-#>8F3H!PI+L@_6.C M%TVNUP]T2I5;IO!(5^;:-O04OBD"%(?&!_6-0F ,%6&ZZ!SINK4'W%MJBV_< M+_&UL4$L! A0#% @ MUTMM6)L[1TY9!P VU< !4 ( !1SL ')E;F(M,C R-# S @,3%?<')E+GAM;%!+!08 !0 % #X! #30@ ! end XML 16 e5493_8-k_htm.xml IDEA: XBRL DOCUMENT 0001527728 2024-03-11 2024-03-11 iso4217:USD shares iso4217:USD shares false 0001527728 8-K 2024-03-11 RENOVARO INC. DE 001-38751 45-2559340 2080 Century Park East Suite 906 Los Angeles CA 90067 (305) 918-1980 false false false false Common Stock, par value $0.0001 per share RENB NASDAQ false